Citigroup’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8M | Buy |
|
|||||
|
2025
Q1 | $7.27M | Buy |
|
|||||
|
2024
Q4 | $7.56M | Buy |
|
|||||
|
2024
Q3 | $3.42M | Buy |
|
|||||
|
2024
Q2 | $1.6M | Sell |
|
|||||
|
2024
Q1 | $8.95M | Buy |
|
|||||
|
2023
Q4 | $4.13M | Buy |
|
|||||
|
2023
Q3 | $3.81M | Buy |
|
|||||
|
2023
Q2 | $2.26M | Sell |
|
|||||
|
2023
Q1 | $4.52M | Buy |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $37K | Sell |
|
|||||
|
2022
Q2 | $85K | Buy |
|
|||||
|
2022
Q1 | $28K | Buy |
|
|||||
|
2021
Q4 | $3K | Buy |
|